TY  - RPRT
TI  - Galectin-3 as a new negative checkpoint of the immune response is the key target for effective immunotherapy against prostate cancer
AU  - Tiraboschi, C.
AU  - Gentilini, L.
AU  - Corapi, E.
AU  - Jaworski, F. M.
AU  - Velazquez, C.
AU  - Chauchereau, A.
AU  - Laderach, D. J.
AU  - Compagno, D.
PY  - 2019
DO  - 10.1101/763409
UR  - https://www.biorxiv.org/content/10.1101/763409v1
ID  - 10.1101/763409
ER  -